疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

* v( A! U# K6 p; t

Vaccines, 6th Edition

- v. G/ g5 Q' k* I6 j* kApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
. m4 l3 a4 y9 B8 s4 ?7 e( c2 Vaccine immunology 14
3 The vaccine industry 33
* g* A' S  s, K6 `2 Z( x4 Vaccine manufacturing 44
& \% M7 x2 H: I4 R' I  c5 Evolution of adjuvants across the centuries 58
  c$ f, f# }4 V/ F4 g8 U4 |6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
7 [* x0 l! H' R/ {4 P, F# o10 Anthrax vaccines 127
11 Cholera vaccines 141
5 O( U0 _" D$ Q( o9 i2 V12 Diphtheria toxoid 153
& W7 E+ {. }1 E& c13 Haemophilus influenzae vaccines 167
7 C3 `$ T1 l( U$ F/ b6 x+ v14 Hepatitis A vaccines 183
5 G- `4 ]- a; ^, v# G( k15 Hepatitis B vaccines 205
  S% e" q, K0 v# o! U) ?16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
% p3 t/ @# ~8 `18 Influenza vaccine-live 294
, u) t7 C% ?' ?19 Japanese encephalitis vaccines 312
. ^" a! C0 b2 G! U- Z20 Measles vaccines 352
( j4 f/ [* @, P6 r) x$ E21 Meningococcal vaccines 388
22 Mumps vaccine 419
5 Y# Q& y" j- y, H7 |( k- S23 Pertussis vaccines . 447
; r2 C* r1 O* Q0 w24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
% i4 {* M. h' ^3 f6 s0 m( d5 J26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
1 i% W" p- F* z4 M1 w% a4 W% d, m0 R29 Rabies vaccines .646
30 Rotavirus vaccines . 669
' A4 ]9 z  J" {# g- s31 Rubella vaccine 688
* G9 ]$ W* K8 c( n$ e+ T32 Smallpox and vaccinia 718
7 v' m; B% o6 n8 B33 Tetanus toxoid 746
2 Z2 V9 v' m$ @2 T/ Z. J; D' U34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
+ R, s3 Z- s' a7 \, }8 l39 Zoster vaccine 969
! a( S2 G: m' Z40 Combination vaccines 981
3 t) D& U4 }5 i7 D$ L5 s  w0 E+ sSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
9 s6 O9 w( k1 m1 G7 Y& b; k( A" o46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
8 S/ f9 m- r" Y1 n2 L48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
- t  I& u' V. u2 C8 ~53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
, g- t* |# A$ |- {' ]' G. P55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
7 A- L5 R. ]% T' C57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
! q  A7 N& K3 k: R2 S59 Streptococcus group B vaccines 1176
3 L6 M: e# s" ^0 M, X) h1 U60 Technologies for making new vaccines 1182
8 ]4 m2 g5 c& ?7 {6 `5 u; ]61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
, h; d: g5 f: e# A& V' {" {SECTION 4: Vaccination of special groups
% l" Q  G) u: f, ~- N63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
' ~) U5 o$ X) y67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
+ R; k4 Y8 X5 d3 X3 t8 m" Q70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
8 p# ]9 _; V9 d73 Regulation and testing of vaccines 1427
6 B, r* P7 E! P# s74 Regulation of vaccines in Europe 1447
, J2 o. u+ K# g, x75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
2 C+ Z& K  [8 Q) H5 q77 Legal issues . 1481
7 r( |! `# X0 }$ a- g0 `& A78 Ethics 1508
2 y8 w/ m+ p5 P6 `6 S+ A
; g, f9 v/ Q4 A

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

" t( c/ d9 F6 U5 tVaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606

; i, P  K2 _% M* L/ B* \" B: P9 jSECTION 1: General aspects of vaccination
+ o- \3 N1 ]. b' e( k( w1 A short history of vaccination 1
2 Vaccine immunology 14
+ p3 ~* C' r5 i+ }9 G3 The vaccine industry 33
3 G4 C0 U9 `% u/ M) ~4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
" R( v6 _! z7 M8 C8 General immunization practices 88
: e! G2 H8 d% D, C/ N, TSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
# y! N4 _! T1 b/ l12 Diphtheria toxoid 153
1 @6 _/ D# e/ Q* X( J' B. {13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
: ]! `2 v4 p& i+ Q- q2 y17 Inactivated influenza vaccines 257
2 m' V6 Q) X' L& n18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
2 v+ }2 c# g; J4 V, M25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
, m8 N8 Q6 K- i+ i. z3 ]' ]- ^27 Poliovirus vaccine-inactivated . 573
( {: Z$ g: Y4 R' B2 M' E28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
8 c& r/ F  G3 C+ F0 b# T6 I5 \0 K32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
! B3 |. j0 j) |5 w! U$ O% N34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
4 a1 H7 L+ A  R37 Varicella vaccine 837
/ `1 ?2 [0 ^; i1 u4 @% J38 Yellow fever vaccine 870
39 Zoster vaccine 969
7 l8 p, p6 r7 M40 Combination vaccines 981
# {/ R; g5 I- x# t7 z5 JSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
+ O. ~' g# X( u9 W! G& V# m' M43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
" K2 k9 w3 `( k7 e48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
/ ]$ b. c) b9 d2 E* t& M50 Herpes simplex virus vaccines 1090
  c! W5 T* d; C; X; H4 T$ ]# {51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
9 n) c$ J8 m9 f53 Malaria vaccines 1133
. p. ^4 I; S2 U/ x1 N54 Noninfectious disease vaccines 1138
4 h7 D7 E5 m( C1 I( Z, }$ o5 @7 A55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
+ I5 v3 I- h9 J7 l56 Parasitic disease vaccines 1154
( Q% v/ _8 w5 }0 Y5 k: t& o5 H! t: r57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
/ H/ V, l0 u7 q3 U& ?; r6 A59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
/ k" O$ b$ U5 Q( f- X5 @- s3 E6 ], ]63 Vaccination of immunocompromised hosts 1243
" P$ Q. o8 K9 s$ c6 L6 G1 n3 C64 Vaccination of human immunodeficiency virus-infected persons 1257
2 `% d/ e& `1 b& r1 k& w7 _65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
& i- l1 U; r3 z) S5 o& h1 zSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
) B: X3 w( f$ r68 Immunization in Europe . 1334
4 f) h: K9 m0 r" H: x69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
* U4 ^6 F, J; a  C7 h0 J, q71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
+ j: ^# g0 Y) V6 c$ v74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
5 ^: [% \) W5 k- ?+ n: F76 Vaccine safety 1464
. q- E  K$ x4 h0 z$ c' I% n' E77 Legal issues . 1481
78 Ethics 1508
. P  y7 I& n( P3 F# z
- v0 L/ Q; i& z' [- H0 ?% J
2 c0 E) l; i5 g1 M/ c1 P3 z

casarett

Vaccines, 6e, 2012

9 g( X! ~3 R+ s) rHardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
. o" V% J: G6 N, k+ YLanguage: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)
7 q! @* h7 I. d5 i' S1 y3 k
2013 BMA Medical Book Awards Highly Commended in Public Health!
) z: r" ]% m) J# F$ EApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
; U  M% @0 s' [
0 y+ w/ _6 }5 p2 W' D( b+ e. NGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
0 G/ Y' C' q4 j5 w0 @7 KPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
5 Q1 \& Q$ F5 g; ^( _5 F( W$ NStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
3 u5 m5 ~; ?9 t& ?# i3 A! C$ ?0 _
Download link: http://pan.baidu.com/s/1i5NxwLR
! m( e9 W9 B% A8 X* V* Z" ]Code for downloading: dv96
4 [( H* J* M0 ]  f6 R